Cognito Therapeutics Raises $105M in Series C Funding Round

Cognito Therapeutics secures $105 million in Series C funding to advance non-invasive neuroprotective therapies for neurodegenerative diseases.

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here